Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study. [electronic resource]
Producer: 20191206Description: 352-359 p. digitalISSN:- 1879-0844
- Acetamides -- administration & dosage
- Adult
- Antihypertensive Agents -- administration & dosage
- Cardiac Surgical Procedures -- adverse effects
- Disease Progression
- Double-Blind Method
- Drug Monitoring -- methods
- Early Medical Intervention -- methods
- Female
- Heart Defects, Congenital -- complications
- Humans
- Hypertension, Pulmonary -- diagnosis
- Male
- Middle Aged
- Proportional Hazards Models
- Pyrazines -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.